Giancipoli, Ermete
Guglielmi, Antonella http://orcid.org/0009-0000-6465-0449
Bux, Anna Valeria
Clima, Giulia Maria Emilia
Pignatelli, Francesco
Boscia, Francesco
Viggiano, Pasquale
Boscia, Giacomo
Fortunato, Francesca
Besozzi, Gianluca
Niro, Alfredo
Dore, Stefano
Iaculli, Cristiana
Article History
Received: 20 March 2024
Accepted: 21 May 2024
First Online: 4 June 2024
Declarations
:
: Ermete Giancipoli and Francesco Boscia are consultants for Roche. Antonella Guglielmi, Anna Valeria Bux, Giulia Clima, Francesco Pignatelli, Pasquale Viggiano, Giacomo Boscia, Francesca Fortunato, Gianluca Besozzi, Alfredo Niro, and Stefano Dore have nothing to disclose. Cristiana Iaculli had a financial arrangement with Roche within the past 12 months. Anna Valeria Bux has changed her affiliation to “Department of Ophthalmology, Ospedale di Venere, Carbonara di Bari, Via Ospedale di Venere 1, 70131, Bari (BA)—Italy”.
: This study followed the principles outlined in the Declaration of Helsinki. Informed consent for use of faricimab was obtained from all patients before treatment initiation. By signing it, patients also authorized their anonymized data could eventually be used for scientific purposes in the future. Patients were treated with approved diagnostic and therapeutic procedures according to generally accepted standards of care. A formal notification of the study protocol was sent to our local Ethics Committee (Policlinico Riuniti—University of Foggia). Ethical approval was waived for this study.